Clinical Trials Browser

Completed × Renal Insufficiency × Clear all

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

Clinical Trials

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

SELF-BREATHE RCT for Chronic Breathlessness

STONE

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

IRMYG

POM Renal

Mesenchymal Stem Cells After Renal or Liver Transplantation

A Study of Special Use Results Surveillance of Revlimid 5mg Capsules

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

LVPK

OPTIMAL

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

OPTI-AGED

Study of Copanlisib in Hepatic or Renal Impairment

Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)

RENAL

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients

A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function

Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

EuLITE

JASINT1

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

RENVEL

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

TOP

Pharmacokinetics in Subjects With Renal Impairment

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure

Safinamide Renal Impairment Trial

Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure

Bortezomib-Dexamethasone-Doxorubicin-Study

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

Oxaliplatin in Cancer Patients With Impaired Kidney Function

Multidisciplinary Inpatient Palliative Care Intervention